Story thread · 6 reports / 6 sources
Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?
finance.yahoo.com · 5d
How the coverage leans
Across 6 sources · syndicated copies counted once
First report: Bristol Myers' Blood Cancer Cell Therapy Succeeds in Mid-stage Trial — medscape.com, 6d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.